The weekly litigation news digest is live. Subscribe now

IP Verse

Adam6 Mice - EP2578688

The patent EP2578688 was granted to Regeneron Pharmaceuticals on Feb 8, 2023. The application was filed on Feb 24, 2012 under application number EP12192727A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2578688

REGENERON PHARMACEUTICALS
Application Number
EP12192727A
Filing Date
Feb 24, 2012
Status
Patent Maintained As Amended
Jan 6, 2023
Publication Date
Feb 8, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
KYMABMay 4, 2020CMS CAMERON MCKENNA NABARRO OLSWANGADMISSIBLE

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2007280945
DESCRIPTIONUS6586251
DESCRIPTIONUS6596541
DESCRIPTIONUS7105348
DESCRIPTIONUS7294754
DESCRIPTIONUS7473557
DESCRIPTIONUS7576259
DESCRIPTIONUS7659442
EXAMINATIONWO2011004192
EXAMINATIONWO2011158009
EXAMINATIONWO2013061098
EXAMINATIONWO2013079953
OPPOSITIONEP2550363
OPPOSITIONWO02066630
OPPOSITIONWO2011004192
OPPOSITIONWO2011158009
OPPOSITIONWO2013079953
OTHEREP2793567
OTHERWO02066630
SEARCHUS2004018626

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents